FRANKLIN, Tenn., Feb. 17, 2011 /PRNewswire/ — Georgia Health
Sciences University, Augusta, GA exhibited a
poster at the recent 11th National Conference on Cancer Nursing
Research in Los Angeles, in which their clinical study showed RyMed Technologies‘ zero
displacement InVision-Plus®
IV Connector significantly decreased the incidence of
catheter-related bloodstream infections (CR-BSIs) by 92.6% on
average when compared to a simple split septum with negative
displacement IV connector (Becton-Dickinson Q-Syte®) and a
reversed split-septum device with negative displacement IV
connector (ICU Medical Clave®). No clinical studies have
been published comparing different types of connectors in oncology
patients on CR-BSIs. CR-BSIs can cause treatment delays, add
time to nursing care, increase costs, increase mortality and
decrease quality of life for the patient and family.
The purpose of the study was to determine infection rates for a
split septum valve, a negative reversed split-septum valve and an
intraluminal protection device (IPD) with zero displacement in both
critical care and medical in-patient oncology patients.
Detailed results:
CR-BSI incidences decreased 96.3%, from 2.9 to 0.1 infections per
1,000 catheter days, when the RyMed InVision-Plus® needleless
IV connector was used compared to the Becton-Dickinson’s
Q-Syte® product.
CR-BSI incidences decreased 88.9%, from 3.7 to 0.4 infections per
1,000 catheter days, when the RyMed InVision-Plus® needleless
IV connector was used compared to the ICU Medical Clave®
product.
Overall, 92.6% decrease in infection rate was found when using the
RyMed InVision-Plus® with Neutral Advantage™
technology.</
‘/>”/>
